The 27-provider practice to revolutionize patient communication and operational efficiency with the AI-powered contact center solutionWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest...
Hyperbaric oxygen therapy pioneer and Aviv Clinics medical advisor honored for research and service to veterans and patients with stroke,...
PITTSBURGH, Aug. 25, 2025 /PRNewswire/ -- "I wanted to create a smart watch system that would provide supportive reminders to...
NEW ORLEANS, Aug. 25, 2025 /PRNewswire/ -- Nest Health, the nation's leading in-home, whole-family care provider for families on Medicaid,...
Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY /...
The GenAI-powered platform automates benefit verification, prior authorization, and payer follow-up to reduce treatment delays and manual burdenSAN FRANCISCO--(BUSINESS WIRE)--Develop...
MARLTON, N.J., Aug. 20, 2025 /PRNewswire/ -- Tribe Intensive NJ, a premier dual-diagnosis addiction treatment provider offering both partial hospitalization...
U.S. Senate Appropriations Report Further Validates Adial’s Therapeutic Approach and Promotes a More Contemporary Patient Focused Regulatory EnvironmentGLEN ALLEN, Va.,...
The Investment is part of BrainsWay’s ongoing strategy to acquire minority positions in leading U.S. mental health providers to help...
After a successful pilot, Dismas Charities partners with The Change Companies to bring individualized, digital-first programming to justice-involved individuals. CARSON...
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4...
~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed,...
DEA Administrator Terrance Cole has also signaled a tough line: "Everybody knows my stance on marijuana after 30 plus years...
We're Out of Time Podcast Host & Addiction Recovery Expert Richard Taite Endorses Bereaved Parents' Nationwide, In-School Fentanyl Prevention Effort...
GLEN ALLEN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
Initiates Critical Milestone, Launching Phase 3 Trial of PF614 to Advance Next-Generation Opioid Therapy Toward Regulatory ApprovalReceives $5.3 Million Installment...
- Revenue of $1.9 Million consistent with the year-ago period- Revenue led by Population Health's growth up 197% compared to...
Manuscript accepted for publication in Frontiers in Pharmacology, "Oral Administration of Ketamir-2, a Novel Ketamine Analog, Attenuates Neuropathic Pain in...
Acquisition Poised to Drive Substantial Shareholder Value Through Innovative Technologies, Projected Multi-Million Revenues, and Strategic Leadership Alignment: Amin Janmohamed Steps...
LAGUNA NIGUEL, Calif., Aug. 7, 2025 /PRNewswire/ -- Alleva, the premier EMR platform for behavioral health, proudly announces the release...